Congenital heart diseases represent a diverse group of structural abnormalities present from birth, impacting the heart's functionality and circulation. These conditions, ranging from atrial septal defects to more complex anomalies like hypoplastic left heart syndrome, often require early intervention. Advances in diagnostic tools, such as fetal echocardiography and genetic screening, have enabled earlier detection and better planning of treatment strategies. Surgical innovations, including minimally invasive techniques and hybrid procedures, continue to improve survival rates. Additionally, the long-term management of congenital heart diseases focuses on preventing complications, ensuring that patients lead healthier, more active lives through comprehensive and personalized care.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India